Role of contrast-enhanced spectral mammography in the assessment of residual disease following neoadjuvant chemotherapy in patients with breast cancer

Role of contrast-enhanced spectral mammography in the assessment of residual disease following neoadjuvant chemotherapy in patients with breast cancer

Abstract Background Neoadjuvant chemotherapy (NAC) is currently one of the most commonly utilized treatment options for patients with breast cancer. Evaluating residual disease following NAC is vital in post-chemotherapy treatment planning. Underestimation or overestimation of the residual disease m...

Full description

Bibliographic Details
Main Authors: Hebatalla Elkassas, Samar M. El-Maadawy, Sherihan Mahmoud Saad, Amira H. Radwan, Sherihan W. Y. Gareer
Format: Article
Language:English
Published: SpringerOpen 2022-12-01
Series:The Egyptian Journal of Radiology and Nuclear Medicine
Subjects:
Contrast-enhanced spectral mammography
Breast cancer
Neoadjuvant chemotherapy
Online Access:https://doi.org/10.1186/s43055-022-00935-5

Internet

https://doi.org/10.1186/s43055-022-00935-5

Similar Items